New Drug Approvals Archive - July 2005
Rozerem (ramelteon) Tablets
Date of Approval: July 22, 2005
Company: Takeda Pharmaceuticals North America, Inc.
Treatment for: Insomnia
Rozerem (ramelteon) is an orally active hypnotic indicated for the treatment of insomnia characterized by difficulty with sleep onset.
Read more: Rozerem (ramelteon) FDA Approval History
New Formulation Approved: February 24, 2016
Read more: Aczone (dapsone) FDA Approval History